Cedric Nasnas

4PUBLICATIONS
36CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 04, 2024
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy.

Wei-Ying Jen, Koji Sasaki, Farhad Ravandi

|Jul 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL.

Hagop Kantarjian, Nicholas J Short, Fadi G Haddad

|Feb 28, 2024
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.

Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf

|Jan 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.

Nicholas J Short, Naval Daver, Courtney D Dinardo

Pageof 1

Frequent Collaborators

4 joint publications

Naval G Daver

3 joint publications

Nicholas J Short

3 joint publications

Ghayas C Issa

2 joint publications

Courtney D Dinardo